EUS-EG: Endoscopic Ultrasound Elastography in Pancreatic Masses

Sponsor
University of Medicine and Pharmacy Craiova (Other)
Overall Status
Completed
CT.gov ID
NCT00909103
Collaborator
University Hospital, Gentofte, Copenhagen (Other), Odense University Hospital (Other), Institut Paoli-Calmettes (Other), San Raffaele University Hospital, Italy (Other), UCL (Univ), Brussels, Belgium (Other), Glasgow Royal Infirmary (Other), Caritas-Krankenhaus Bad Mergentheim (Other), University of Bergen (Other), University of Witten/Herdecke (Other), Newcastle-upon-Tyne Hospitals NHS Trust (Other)
285
18
18
15.8
0.9

Study Details

Study Description

Brief Summary

The aim of the study is to assess elastography during EUS examinations of focal pancreatic masses, and to consequently differentiate benign versus malignant pancreatic masses in a prospective multi-center design.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Ultrasound elastography is a recent ultrasound method used for the calculation of tissue elasticity distribution in real-time. The method allows the reconstruction of tissue elasticity (i.e. the elasticity modulus) and reveals directly the physical properties of the tissue, consequently showing different tissue hardness patterns that are determined by diseases. Tissue elastography can be easily performed real-time with conventional probes, including the linear EUS probes used for the examination of the pancreas. The calculation of tissue elasticity distribution is performed in real-time and the examination results are represented as transparent overlay colour images overimposed on the conventional gray-scale B-mode images.

    Ultrasound elastography was previously used for the diagnosis of breast lesions, prostate cancer and thyroid nodules. However, the value of endoscopic ultrasound elastography for the diagnosis of pancreatic focal masses is not clear for the current moment, as some authors couldn't differentiate benign and malignant pancreatic tumors. Moreover, the intense fibrotic reaction and calcifications in chronic pancreatitis induce strain differences, and it is not clear if elastography is sensitive enough to detect them.

    The study protocol is based on a semi-quantitative approach of EUS elastography data (movies) consisting of characterization of manually user-defined regions of interest, based on the hue histograms of the individual focal masses. Due to the inherent bias induced by selection of images from a dynamic sequence of EUS elastography, we have previously reported on the utility of using computer-aided diagnosis by averaging images from a dynamic sequence of EUS elastography. A special plugin (based on the ImageJ software, NIH, Bethesda, MD, USA) is used to compute hue histograms on average EUS elastography images, while the hue histograms values for each patient (0 to 255 values) are further used to classify the patients with benign and malignant lesions.

    Ultrasound elastography will be performed during an usual EUS examination (7.5 MHz frequency), with two movies of 10 seconds recorded on the embedded HDD in order to minimize variability and to increase repeatability of acquisition. A two panel image with the usual conventional gray-scale B-mode EUS image on the right side and with the elastography image on the left side will be used. The region of interest will be preferably larger than the focal mass, in order to include the surrounding structures. In order to minimize the human bias, all the post-processing and computer analysis of digital movies will be performed within the IT Center in Craiova, with all programmers and statisticians being blinded to the clinical, pathological and imaging data, with the exception of the average hue histogram values calculated from a second region of interest manually traced around the focal mass.

    The study design is prospective, blinded and multi-center, comparing endoscopic ultrasound elastography (EUS-EG) results for the detection and characterization of focal pancreatic masses by using artificial intelligence techniques, in comparison with the gold standard represented by pathology. The study will be performed with the approval of the institutional board review of each center.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    285 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Computer-aided Diagnosis of Endoscopic Ultrasound Elastography Used in the Differentiation of Focal Pancreatic Masses
    Study Start Date :
    Jun 1, 2008
    Actual Primary Completion Date :
    Nov 1, 2009
    Actual Study Completion Date :
    Dec 1, 2009

    Arms and Interventions

    Arm Intervention/Treatment
    Pancreatic adenocarcinoma

    Patients diagnosed with solid pancreatic adenocarcinoma masses, with cytological / histological confirmation

    Chronic pancreatitis

    Patients diagnosed with solid pancreatic tumor masses with all the criteria fulfilled to exclude pancreatic cancer

    Outcome Measures

    Primary Outcome Measures

    1. Value of endoscopic ultrasound elastography for the differential diagnoses of pancreatic masses. [18 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No

    Inclusion criteria

    • Patients diagnosed with solid pancreatic tumor masses, with cytological / histological confirmation

    • Age 18 to 80 years old, men or women

    • Signed informed consent for EUS with elastography and FNA biopsy

    Exclusion criteria

    • Prior surgical treatment with curative intent or chemo-radiotherapy

    • Patients diagnosed with mucin producing tumors, pancreatic cystic tumors, etc.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Erasme University Brussels Belgium
    2 Universite Chatolique Louvain Brussels Belgium
    3 Gentofte University Hospital Copenhagen Denmark
    4 University Hospital Odense Denmark
    5 Institute Paoli Calmettes Marseille France
    6 Caritas-Krankenhaus Bad Mergentheim Germany
    7 St. Josef Hospital Bochum Germany
    8 SRH Klinik Gera Germany
    9 University Clinic Mainz Mainz Germany
    10 Dr.Horst-Schmidt-Klinik Wiesbaden Germany
    11 HELIOS Klinikum Wuppertal, University of Witten/Herdecke Wuppertal Germany
    12 Hospital San Raffaele Milan Italy
    13 Erasme Medisch Centrum Rotterdam Netherlands
    14 University of Haukeland Bergen Norway
    15 University of Medicine and Pharmacy Craiova Craiova Romania
    16 University Hospital Santiago Santiago Spain
    17 Glasgow Royal Infirmary Glasgow United Kingdom
    18 Newcastle Upon Tyne Hospitals Newcastle United Kingdom

    Sponsors and Collaborators

    • University of Medicine and Pharmacy Craiova
    • University Hospital, Gentofte, Copenhagen
    • Odense University Hospital
    • Institut Paoli-Calmettes
    • San Raffaele University Hospital, Italy
    • UCL (Univ), Brussels, Belgium
    • Glasgow Royal Infirmary
    • Caritas-Krankenhaus Bad Mergentheim
    • University of Bergen
    • University of Witten/Herdecke
    • Newcastle-upon-Tyne Hospitals NHS Trust

    Investigators

    • Study Director: Adrian Saftoiu, Professor, University of Medicine and Pharmacy Craiova, Romania

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00909103
    Other Study ID Numbers:
    • EUS-EG001
    • EUS-EG-UMFCV-RO
    First Posted:
    May 27, 2009
    Last Update Posted:
    Jan 12, 2010
    Last Verified:
    Jan 1, 2010

    Study Results

    No Results Posted as of Jan 12, 2010